These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32236161)

  • 1. Prostate Cancer Therapeutics and Their Complications: A Primer for the Primary Care Provider.
    Brownlee Z; De Souza A; Koffer PP; DiPetrillo TA; Mega AE
    R I Med J (2013); 2020 Apr; 103(3):41-45. PubMed ID: 32236161
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristics and management of erectile dysfunction after various treatments for prostate cancer.
    Soh J; Kaiho Y; Kikuchi E; Oya M; Yoshioka K; Nakagami Y; Hatano T; Ozu C; Horiguchi Y; Namiki K; Tachibana M; Hisasue S; Tanaka N; Asakawa I
    Int J Urol; 2010 Aug; 17(8):689-97. PubMed ID: 20590940
    [No Abstract]   [Full Text] [Related]  

  • 3. [Toxicity of multimodal regimens in prostate cancer].
    Hennequin C
    Prog Urol; 2019 Jun; 29 Suppl 1():S35-S41. PubMed ID: 31307629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors.
    Taneja SS
    J Urol; 2013 Nov; 190(5):1763-4. PubMed ID: 24120777
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors.
    Griebling TL
    J Urol; 2014 Apr; 191(4):1056. PubMed ID: 24703136
    [No Abstract]   [Full Text] [Related]  

  • 6. Measuring self-reported sexual function in men with prostate cancer.
    Brucker PS; Cella D
    Urology; 2003 Oct; 62(4):596-606. PubMed ID: 14550425
    [No Abstract]   [Full Text] [Related]  

  • 7. [Quality of life of patients with locally-advanced prostate cancer as a criterium of therapeutic effectiveness].
    Kaprin AD; Kostin AA; Tsybul'skiĭ AD
    Vopr Onkol; 2009; 55(3):285-90. PubMed ID: 19670727
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.
    Obata H; Shiota M; Akitake N; Takeuchi A; Kashiwagi E; Dejima T; Kiyoshima K; Inokuchi J; Tatsugami K; Eto M
    Anticancer Res; 2017 Oct; 37(10):5631-5637. PubMed ID: 28982880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of complications of prostate cancer treatment.
    Michaelson MD; Cotter SE; Gargollo PC; Zietman AL; Dahl DM; Smith MR
    CA Cancer J Clin; 2008; 58(4):196-213. PubMed ID: 18502900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-cancer-associated hypercoagulability: do we need to worry about androgen deprivation?
    Saylor PJ; Fogerty AE
    Lancet Oncol; 2010 May; 11(5):406-7. PubMed ID: 20395175
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular and Skeletal-related Events Following Localized Prostate Cancer Treatment: Role of Surgery, Radiotherapy, and Androgen Deprivation.
    Wallis CJ; Mahar AL; Satkunasivam R; Herschorn S; Kodama RT; Lee Y; Kulkarni GS; Narod SA; Nam RK
    Urology; 2016 Nov; 97():145-152. PubMed ID: 27502032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does one have a sexual life after prostate cancer treatment? ].
    Cosset JM
    Cancer Radiother; 2002 May; 6(3):183-7. PubMed ID: 12116844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen deprivation therapy for localized and nonmetastatic prostate cancer: too much of a good thing?
    Konijeti R; Kibel AS
    Eur Urol; 2012 Jun; 61(6):1129-30; discussion 1131. PubMed ID: 22445550
    [No Abstract]   [Full Text] [Related]  

  • 14. Competing risks for patients with localized prostate cancer.
    Seidenfeld J; Samson DJ; Albertsen PC
    J Natl Cancer Inst; 2007 Oct; 99(20):1498-9. PubMed ID: 17925533
    [No Abstract]   [Full Text] [Related]  

  • 15. Locally advanced prostate cancer: effective treatments, but many adverse effects.
    Prescrire Int; 2013 Jan; 22(134):18-20, 22-3. PubMed ID: 23367679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New trial data do not end the PSA screening debate.
    Vastag B
    J Natl Cancer Inst; 2009 Jun; 101(12):844-5. PubMed ID: 19509364
    [No Abstract]   [Full Text] [Related]  

  • 17. Effective treatment for early-stage prostate cancer--possible, necessary, or both?
    Smith MR
    N Engl J Med; 2011 May; 364(18):1770-2. PubMed ID: 21542749
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic options in hormone refractory prostate carcinoma].
    Graefen M; Hammerer P; Haese A; Huland H
    Urologe A; 2000 May; 39(3):267-73. PubMed ID: 10872254
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
    Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease associated with androgen-deprivation therapy: time to give it due respect.
    Basaria S
    J Clin Oncol; 2015 Apr; 33(11):1232-4. PubMed ID: 25753444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.